^
CANCER:

Adrenal Cortex Carcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
No biomarker
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
A1
No biomarker
Adrenal Cortex Carcinoma
cisplatin + carboplatin + etoposide IV + mitotane + SGN-15
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + doxorubicin hydrochloride + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + doxorubicin hydrochloride + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
streptozocin
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
mitotane + streptozocin
Sensitive
:
A2
MSI-H/dMMR
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
C1
RRM1 underexpression
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
C3
TMB-L
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
C3
MSH2 mutation
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
C4
FGFR3-TACC3 fusion
Adrenal Cortex Carcinoma
erdafitinib
Sensitive
:
C4
TOP2A overexpression
Adrenal Cortex Carcinoma
rubitecan
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
teniposide
Sensitive
:
D
CDK1 overexpression
Adrenal Cortex Carcinoma
DSP-2033
Sensitive
:
D
CDK4 overexpression
Adrenal Cortex Carcinoma
palbociclib
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
etoposide oral
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
pirarubicin
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
mitoxantrone
Sensitive
:
D
AURKA overexpression
Adrenal Cortex Carcinoma
SA033 + AMG 900
Sensitive
:
D
AURKB overexpression
Adrenal Cortex Carcinoma
SA033 + AMG 900
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
idarubicin hydrochloride
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
SA033
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
daunorubicin
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
aclarubicin
Sensitive
:
D